StockData
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. (BCAX) stock

BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$9.60−0.15 (-1.54%)

Close on Nov 17, 2026Market cap $635.26MP/E –Yield –

Bicara Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Bicara Therapeutics's enterprise value was $197.00M on Nov 11, 2026, against $723.44M a year earlier. Over the last 2 years it ranged from -$215.28M to $1.41B, with a median of $427.06M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$197.00M-68.7%
2025Dec 31, 2025$628.96M+47.3%
2024Dec 31, 2024$427.06M–

More Bicara Therapeutics figures

See a number that looks wrong?